Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01431144 · ClinicalTrials.gov registry record · NA
Implant Placement With Simultaneous Gum Grafting
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT01431144: Completed NA study, sponsored by University of Louisville.
NCT01431144 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01431144, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
This study is a comparison of implant placed and simultaneously grafted with either autogenous connective tissue or a connective tissue allograft. The objective is to determine the change in soft tissue thickness and determine if a better result is obtained with the autograft or the allograft. The hypothesis is that there will be no difference in soft tissue thickness over the implant between the autograft and the allograft technique.
Primary Outcome
Soft tissue thickness at the facial osseous crest.
Interventions
- PROCEDURE connective tissue autograft
- PROCEDURE connective tissue allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT01431144 record still lists
NCT01431144 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which connective tissue autograft is the first listed.
NCT01431144 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01431144 about?
NCT01431144 is a clinical study titled "Implant Placement With Simultaneous Gum Grafting". This study is a comparison of implant placed and simultaneously grafted with either autogenous connective tissue or a connective tissue allograft. The objective is to determine the change in soft tissue thickness and determine if a better result is obtained with the autograft or the allograft. The h...
What is the current status of trial NCT01431144?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2011-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01431144?
The interventions under investigation include: connective tissue autograft (PROCEDURE), connective tissue allograft (PROCEDURE).
Who is sponsoring clinical trial NCT01431144?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01431144's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia